Harvard Bioscience Revenue and Competitors
Estimated Revenue & Valuation
- Harvard Bioscience's estimated annual revenue is currently $750M per year.
- Harvard Bioscience's estimated revenue per employee is $1,764,706
- Harvard Bioscience's total funding is $19.5M.
Employee Data
- Harvard Bioscience has 425 Employees.
- Harvard Bioscience grew their employee count by -2% last year.
Harvard Bioscience's People
Name | Title | Email/Phone |
---|---|---|
1 | Sr. VP Operations | Reveal Email/Phone |
2 | Regional VP Sales | Reveal Email/Phone |
3 | Global VP, Research and Development | Reveal Email/Phone |
4 | General Counsel and Corporation Secretary | Reveal Email/Phone |
5 | VP Global People Operations | Reveal Email/Phone |
6 | SVP Sales | Reveal Email/Phone |
7 | VP Sales-Global Distribution & OEM | Reveal Email/Phone |
8 | VP Operations, Division Site Leader | Reveal Email/Phone |
9 | EVP | Reveal Email/Phone |
10 | VP Global Product Management | Reveal Email/Phone |
Harvard Bioscience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Harvard Bioscience?
Harvard Bioscience is a global developer, manufacturer and marketer of innovative, enabling tools for drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. HBIO sells approximately 19,000 products to thousands of researchers in 100 countries though its direct sales force, a 1,000-page catalog, various specialty catalogs and a network of distributors, the most notable of which is Amersham Biosciences (formerly APBiotech). HBIO has sales and manufacturing operations in the United States, the United Kingdom, Germany, Austria and Belgium. It also has sales facilities in France and Canada.
keywords:N/A$19.5M
Total Funding
425
Number of Employees
$750M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Harvard Bioscience News
Harvard Bioscience is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental research,...
Analysts expect Harvard Bioscience, Inc. (NASDAQ:HBIO Get Rating) to post $29.10 million in sales for the current quarter, according to...
Harvard Bioscience, Inc. (NASDAQ:HBIO) Expected to Post Earnings of $0.05 Per Share. Posted by admin on Apr 12th, 2022.
Massachusetts medtech company Harvard Bioscience’s (NSDQ:HBIO) announced today that it plans to cut about 13% of its global workforce, expecting to reap about $2 million in annual savings. Harvard Bioscience plans to focus its efforts and funds on expanding its footprint in China and advancing ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $137.9M | 486 | 9% | N/A |
#2 | $355.3M | 875 | 8% | N/A |